Fatty alcohol esters
TARGETMOL CHEMICALS INC Larazotide acetate 10MG
Also available in 1 mg, 5 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. Larazotide acetate is a synthetic peptide. It functions as a tight junction regulator and reverses leaky junctions to their normally closed state. Purity 95.53%
Medchemexpress LLC PNC-28 acetate | 98.8% | 3509.13 (free acid) | 1 MG
PNC-28 acetate is a peptide derived from the mdm-2-binding domain (residues 17-26) of the p53 protein, incorporating a membrane crossing-penetratin sequence. It is used for pancreatic cancer research. For research use only; not for patient use. PNC-28 blocks the growth of lethal human pancreatic cancer cell lines in vitro and inhibits tumor growth in vivo.
- High purity of 98.79%
- Suitable for in vitro and in vivo pancreatic cancer research
- Supplied as a solid, white to off-white appearance
- Sequence: Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Rr-Asn-Gln-Phe-Trp-Val-Lys-Vl-Gln-Arg-Gly
- Soluble in H2O at 100 mg/mL (requires ultrasonic)
- Sealed storage under nitrogen, away from moisture and light is recommended
Medchemexpress LLC Semaglutide (acetate) | 1997361-85-9 | 99.9% | 4113.58 (free base) | 500 UG
Semaglutide (acetate) | 1997361-85-9 | 99.9% | 4113.58 (free base) | 500 UG
Apexbio Technology LLC Bradykinin (acetate) 6846-03-3 10mg
Bradykinin acetate (CAS 6846-03-3) is a peptide agonist targeting G protein-coupled B1 and B2 receptors It is designed to activate bradykinin receptors thereby modulating inflammatory responses vascular tone and endothelial signaling pathways Bradykinin acetate exerts its biological activity primarily through endothelium-dependent release of nitric oxide and prostacyclin leading to vasodilation Receptor activation also triggers non-vascular smooth muscle contraction increases vascular permeability and mediates pain signaling pathways Based on these pharmacological properties Bradykinin acetate holds research potential in studies of inflammation pain mechanisms and endothelial cell signaling